New device could ease chronic constipation without drugs

NCT ID NCT06833684

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called MOWOOT that uses gentle pulses to help the colon move stool in adults with long-term constipation. About 40 people who are waiting for another treatment (trans-anal irrigation) will try the device daily for a period. The goal is to see if it improves their bowel-related quality of life and satisfaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult people (18 yo or older) of any gender 2. Attending their pre-scheduled on-site visit to the site (The Sir Alan Parks Physiology \& Pelvic Floor Biofeedback Unit \| Central Middlesex Hospital) due to constipation (Symptoms meeting the American College of Gastroenterology definition of chronic constipation: unsatisfactory defaecation characterized by infrequent stool, difficult stool passage or both for at least previous 3 months. 3. Bothered by their constipation 4. Failed biofeedback (in absence of outlet problems) 5. In waiting list to use TAI 6. Able to undertake the treatment with the MOWOOT device or TAI themselves, or with a carer willing to do it 7. Able to understand the study requirements 8. Able to understand written and spoken English (due to questionnaire validity) 9. Able and willing to provide written informed consent to participate Exclusion Criteria: A subject will not be eligible for inclusion in this study if any of the following criteria apply: Disease phenotype exclusion criteria: * Irritable Bowel Syndrome with Diarrhoea (IBS-D) or alternating constipation and diarrhoea (IBSmix): (not due to laxative use) * Inflammatory Bowel Disease (IBD) * Significant outlet problem * Trapping rectocele * Intra anal rectal intussusception * External rectal prolapse Device-related exclusion criteria: * Abdominal perimeter ≤65cm or ≥130cm * Unable to independently use the MOWOOT technology, unless a carer is available daily to assist Other medical conditions, medications and contraindications: * Pregnancy or attempt to become pregnant in the next 6 months. * Previous large bowel resection * Active anorexia or bulimia * Active abdominal cancer * Large inguinal or umbilical hernia * Recent abdominal scars, abdominal wounds or skin disorders that may make abdominal massage uncomfortable * Any condition that contraindicates abdominal massage. * Significant abdominal pain * Participation in another parallel interventional clinical trial or less than 2 months from participation in a previous interventional clinical trial * Planned surgery\* if it might be within trial dates (\* minor surgery not affecting adherence to treatment is allowed)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Constipation chronic idiopathic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Sir Alan Parks Physiology & Pelvic Floor Biofeedback Unit., Central Hospital, Department of Physiology, St Mark's Hospital, The National Bowel Hospital

    RECRUITING

    London, London, NW10 7NS, United Kingdom

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.